Epilepsy in patients with Angelman syndrome caused by deletion of the chromosome 15q11-13

Archives of Neurology

Volumn 63, Issue 1, 2006, Pages 122-128

  Valente, Kette D ^a   Koiffmann, Célia P ^a   Fridman, Cíntia ^a   Varella, Mônica ^a   Kok, Fernando ^a   Andrade, Joaquina Queiroz ^a   Grossmann, Rosi M ^a   Marques Dias, Maria Joaquina ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLONAZEPAM; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

ANAMNESIS; ARTICLE; BRAZIL; CAREGIVER; CHILD; CHROMOSOME 15Q; CHROMOSOME DELETION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; EPILEPSY; EPILEPTIC STATE; FEMALE; FEVER; FOCAL EPILEPSY; GENERALIZED EPILEPSY; HAPPY PUPPET SYNDROME; HUMAN; INTERVIEW; MALE; PARENT; PRIORITY JOURNAL; SEIZURE; TREATMENT OUTCOME;

ADOLESCENT; AGE OF ONSET; ANGELMAN SYNDROME; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 15; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEMALE; FEVER; FOLLOW-UP STUDIES; HUMANS; MALE; TREATMENT OUTCOME;

EID: 30344466930     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.63.1.122     Document Type: Article

References (51)

1. Williams CA, Angelman H, Clayton-Smith J, et al. Angelman syndrome: consensus for diagnostic criteria: Angelman Syndrome Foundation. Am J Med Genet. 1995;56:237-238.
2. Kaplan LC, Wharton R, Elias E, Mandell F, Donlon T, Latt SA. Clinical heterogeneity associated with deletions in the long arm of chromosome 15: report of 3 new cases and their possible genetic significance. Am J Med Genet. 1987;28:45-53.
3. Knoll JH, Nicholls RD, Magenis RE, Graham JM Jr, Lalande M, Latt SA. Angelman and Prader-Willi syndromes share a common chromosome 15 deletion but differ in parental origin of the deletion. Am J Med Genet. 1989;32:285-290.
4. Magenis RE, Brown MG, Lacy DA, Budden S, LaFranchi S. Is Angelman syndrome an alternate result of del(15)(q11q13)? Am J Med Genet. 1987;28:829-838.
5. Nicholls RD, Pai GS, Gottlieb W, Cantu ES. Paternal uniparental disomy of chromosome 15 in a child with Angelman syndrome. Ann Neurol. 1992;32:512-518.
6. Buiting K, Saitoh S, Gross S, et al. Inherited microdeletions in the Angelman and Prader-Willi syndromes define an imprinting centre on human chromosome 15. Nat Genet. 1995;9:395-400.
7. Kishino T, Lalande M, Wagstaff J. UBE3A/E6-AP mutations cause Angelman syndrome. Nat Genet. 1997;15:70-73.
8. Matsuura T, Sutcliffe JS, Fang P, et al. De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome. Nat Genet. 1997;15:74-77.
9. Williams CA, Gray BA, Hendrickson JE, Stone JW, Cantu ES. Incidence of 15q deletions in the Angelman syndrome: a survey of twelve affected persons. Am J Med Genet. 1989;32:339-345.
10. Engel E. Chromosome 15 uniparental disomy is not frequent in Angelman syndrome. Am J Hum Genet. 1991;49:459-460.
11. Dittrich B, Buiting K, Horsthemke B. PW71 methylation test for Prader-Willi and Angelman syndromes. Am J Med Genet. 1996;61:196-197.
12. Burger J, Buiting K, Dittrich B, et al. Different mechanisms and recurrence risks of imprinting defects in Angelman syndrome. Am J Hum Genet. 1997;61:88-93.
13. Singh R, Gardner RJ, Crossland KM, Scheffer IE, Berkovic SF. Chromosomal abnormalities and epilepsy: a review for clinicians and gene hunters. Epilepsia. 2002;43:127-140.
14. Proposal for revised classification of epilepsies and epileptic syndromes: Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia. 1989;30:389-399.
15. Matsumoto A, Kumagai T, Miura K, Miyazaki S, Hayakawa C, Yamanaka T. Epilepsy in Angelman syndrome associated with chromosome 15q deletion. Epilepsia. 1992;33:1083-1090.
16. Sugimoto T, Yasuhara A, Ohta T, et al. Angelman syndrome in three siblings: characteristic epileptic seizures and EEG abnormalities. Epilepsia. 1992;33:1078-1082.
17. Mutirangura A, Greenberg F, Butler MG, et al. Multiplex PCR of three dinucleotide repeats in the Prader-Willi/Angelman critical region (15q11-q13): molecular diagnosis and mechanism of uniparental disomy. Hum Mol Genet. 1993;2:143-151.
18. Buckley RH, Dinno N, Weber P. Angelman syndrome: are the estimates too low? Am J Med Genet. 1998;80:385-390.
19. Kyllerman M. On the prevalence of Angelman syndrome [letter]. Am J Med Genet. 1995;59:405.
20. Petersen MB, Brondum-Nielsen K, Hansen LK, Wulff K. Clinical, cytogenetic, and molecular diagnosis of Angelman syndrome: estimated prevalence rate in a Danish county. Am J Med Genet. 1995;60:261-262.
21. Fombonne E, Simmons H, Ford T, Meltzer H, Goodman R. Prevalence of pervasive developmental disorders in the British nationwide survey of child mental health. J Am Acad Child Adolesc Psychiatry. 2001;40:820-827.
22. Zori RT, Hendrickson J, Woolven S, Whidden EM, Gray B, Williams CA. Angelman syndrome: clinical profile. J Child Neurol. 1992;7:270-280.
23. Minassian BA, DeLorey TM, Olsen RW, et al. Angelman syndrome: correlations between epilepsy phenotypes and genotypes. Ann Neurol. 1998;43:485-493.
24. Laan LA, Renier WO, Arts WF, et al. Evolution of epilepsy and EEG findings in Angelman syndrome. Epilepsia. 1997;38:195-199.
25. Dalla Bernardina B, Fontana E, Zullini E, et al. Angelman syndrome: electroclinical features of ten personal cases. Gaslini. 1995;27(suppl 1, pt 2):75-78.
26. Viani F, Romeo A, Viri M, et al. Seizure and EEG patterns in Angelman's syndrome. J Child Neurol. 1995;10:467-471.
27. Guerrini R, De Lorey TM, Bonanni P, et al. Cortical myoclonus in Angelman syndrome. Ann Neurol. 1996;40:39-48.
28. Buoni S, Grosso S, Pucci L, Fois A. Diagnosis of Angelman syndrome: clinical and EEG criteria. Brain Dev. 1999;21:296-302.
29. Guerrini R, Dravet C, Ferrari AR, et al. The evolution of epilepsy in the most common genetic forms with mental retardation (Down's syndrome and the fragile X syndrome). Pediatr Med Chir. 1993;15(suppl 1):19-22.
30. Stafstrom CE, Patxot OF, Gilmore HE, Wisniewski KE. Seizures in children with Down syndrome: etiology, characteristics and outcome. Dev Med Child Neurol. 1991;33:191-200.
31. Pueschel SM, Louis S, McKnight P. Seizure disorders in Down syndrome. Arch Neurol. 1991;48:318-320.
32. Silva ML, Cieuta C, Guerrini R, Plouin P, Livet MO, Dulac O. Early clinical and EEG features of infantile spasms in Down syndrome. Epilepsia. 1996;37:977-982.
33. Freitas A, Valente K, Varela MC, Fridman C, Koiffmann CP. The complexity of inv dup (15): a mild phenotype associated with heterogeneous electroclinical profile and an imprecise correlation with genotype. Epilepsia. 2003;44(suppl 9):55.
34. Buoni S, Sorrentino L, Farnetani MA, Pucci L, Fois A. The syndrome of inv dup (15): clinical, electroencephalographic, and imaging findings. J Child Neurol. 2000;15:380-385.
35. Cabrera JC, Marti M, Toledo L, Gine R, Vazquez C. West's syndrome associated with inversion duplication of chromosome 15. Rev Neurol. 1998;26:77-79.
36. Bingham PM, Spinner NB, Sovinsky L, Zackai EH, Chance PF. Infantile spasms associated with proximal duplication of chromosome 15q. Pediatr Neurol. 1996;15:163-165.
37. Kobayashi A, Ito M, Okada M, Yoshioka K. A case of 15p tetrasomy associated with infantile spasms [in Japanese]. No To Hattatsu. 1994;26:74-77.
38. Elia M, Guerrini R, Musumeci SA, Bonanni P, Gambardella A, Aguglia U. Myoclonic absence-like seizures and chromosome abnormality syndromes. Epilepsia. 1998;39:660-663.
39. Casara GL, Vecchi M, Boniver C, et al. Electroclinical diagnosis of Angelman syndrome: a study of 7 cases. Brain Dev. 1995;17:64-68.
40. Clayton-Smith J. Clinical research on Angelman syndrome in the United Kingdom: observations on 82 affected individuals. Am J Med Genet. 1993;46:12-15.
41. Buntinx IM, Hennekam RC, Brouwer OF, et al. Clinical profile of Angelman syndrome at different ages. Am J Med Genet. 1995;56:176-183.
42. Nakatsu Y, Tyndale RF, DeLorey TM, et al. A cluster of three GABAA receptor subunit genes is deleted in a neurological mutant of the mouse p locus. Nature. 1993;364:448-450.
43. DeLorey TM, Handforth A, Anagnostaras SG, et al. Mice lacking the beta3 subunit of the GABAA receptor have the epilepsy phenotype and many of the behavioral characteristics of Angelman syndrome. J Neurosci. 1998;18:8505-8514.
44. DeLorey TM, Olsen RW. GABA and epileptogenesis: comparing gabrb3 gene-deficient mice with Angelman syndrome in man. Epilepsy Res. 1999;36:123-132.
45. Ruggieri M, McShane MA. Parental view of epilepsy in Angelman syndrome: a questionnaire study. Arch Dis Child. 1998;79:423-426.
46. Odano I, Anezaki T, Ohkubo M, et al. Decrease in benzodiazepine receptor binding in a patient with Angelman syndrome detected by iodine-123 iomazenil and single-photon emission tomography. Eur J Nucl Med. 1996;23:598-604.
47. Franz DN, Glauser TA, Tudor C, Williams S. Topiramate therapy of epilepsy associated with Angelman's syndrome. Neurology. 2000;54:1185-1188.
48. Sugiura C, Ogura K, Ueno M, Toyoshima M, Oka A. High-dose ethosuximide for epilepsy in Angelman syndrome: implication of GABA(A) receptor subunit. Neurology. 2001;57:1518-1519.
49. Laan LA, Vein AA. A Rett patient with a typical Angelman EEG. Epilepsia. 2002;43:1590-1592.
50. Valente KD. Another Rett patient with a typical Angelman EEG. Epilepsia. 2003;44:873-874.
51. Sgro V, Riva E, Canevini MP, et al. 4p(-) syndrome: a chromosomal disorder associated with a particular EEG pattern. Epilepsia. 1995;36:1206-1214.